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Femorodistal PTFE Bypass Grafting for Severe Limb Ischaemia: Results
of a Prospective Clinical Study Using a New Distal Anastomotic
Technique∗
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Objectives: to analyse graft patency and limb salvage following femorodistal bypass with ePTFE using a new distal
anastomotic technique.
Design: prospective non-randomised study.
Material and methods: one hundred and twenty-nine patients (M:F; 2.23:1; mean age 65.2±10.0 years) underwent
135 operations for severe limb ischaemia. The new anastomosis, constructed entirely from ePTFE, was attached to the
popliteal (21), anterior (46) and posterior (52) tibial, and peroneal (16) arteries. Cumulative primary (PPR) and secondary
patency rates (SPR), limb salvage and survival were analysed using the Kaplan–Meier method.
Results: median follow-up was 45 (range 6 to 72) months. There was no perioperative mortality. PPR and SPR at 1, 2,
3, 4, and 5 years were 63.0%, 44.9%, 35.7%, 33.1% and 27.6% and 74.5%, 55.2%, 44.8%, 43.0%, and 37.6%,
respectively. Cumulative limb salvage was 86.4%, 78.7%, and 73.2% at 1, 3, and 5 years, respectively.
Conclusions: this new anastomotic design was feasible and resulted in acceptable long-term results.
Key Words: Femorodistal bypass; Severe limb ischaemia; ePTFE grafts; Anastomotic technique; Patency rates; Limb
salvage.
Introduction the development of myointimal hyperplasia (MIH)
a new type of distal end-to-side anastomosis was
developed by Scholz in 1992. This, characterised by aArterial bypass to restore flow to a patent distal artery
bifurcated double bulb,14,15 is termed femorocruralhas been established as the most appropriate treatment
patch prosthesis (FCPP). In vitro flow visualisationof lower extremity occlusive arterial disease. Although
experiments using dye distribution techniques andthe greater saphenous vein represents the conduit of
colour-coded Doppler sonography and numerical sim-choice for infrainguinal femorodistal bypass pro-
ulation of the complex flow field have demonstratedcedures,1 there remains a significant percentage of
improved haemodynamics within the FCPP comparedpatients who lack autologous vein of adequate length
to other types of end-to-side anastomosis.15 In par-or quality.2–4 In the absence of adequate autologous
ticular, the flow phenomena associated with the de-vein, expanded polytetrafluoroethylene (ePTFE) has
velopment of MIH could be minimised or even werebeen established as an alternative bypass graft ma-
eliminated within the FCPP.terial.5–8 The patency rates of heterologous grafts, how-
The purpose of the present study was to evaluateever, are clearly inferior to autologous vein grafts.6,8,9
the feasibility, clinical and haemodynamic results as-Several methods have been described to improve the
sociated with the use of the FCPP.patency of below-knee ePTFE arterial grafts including
venous cuff techniques10–12 and arteriovenous fistula.13
Materials and MethodsBecause of the importance of haemodynamics for
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or severe ischaemia and who required infragenicular
bypass surgery and in whom no greater or lesser
saphenous vein was available, were eligible. Age, sex,
and the co-morbidity and risk factors were recorded.
Usable autologous vein was defined by duplex ultra-
sound and/or surgical explantation as a greater or
lesser saphenous vein that had a diameter of greater
than 3 mm after dilatation and one that permitted
passage of a catheter through the entire lumen. Patients
underwent preoperative non-invasive testing and di-
gital subtraction angiography (DSA) prior to surgery
whenever possible. DNA studies were used to assess
the runoff status, including the number of patent crural
Fig. 1. The femorocrural patch prosthesis (FCPP) constructed en-vessels and the integrity of the primary plantar arch
tirely from ePTFE. Note the characteristic double bulb and theartery. bifurcated configuration allowing elimination of the stagnation point
Primary patency was defined as continuous graft and conversion of an end-to-side into two end-to-end anastomoses.
patency, uninterrupted by any intervention on the
graft. Secondary patency was defined as patency up (Fig. 2a), proceeding first on the superior edge of the
to the time of final graft closure and included the arteriotomy towards the proximal apex and around it
results of reintervention for thrombosed or failing to the inferior edge (Fig. 2b). Thus the length of the
grafts. Limb salvage was defined as the preservation arteriotomy could be exactly adapted to the size of
of a viable limb with a functional portion of the foot. the patch. Once the proximal segment of the FCPP
Patients were anticoagulated postoperatively and anastomosis had been sutured into place, the distal
reviewed at 1 month and 3 months after re- part was created, again adapting the arteriotomy to
vascularisation, and at 6-month intervals thereafter. the distal part of the patch (Fig. 2c) analogous to the
Patency was confirmed by the presence of distal pulses, proximal segment. Suturing was continued on the
a persistent rise in ankle–brachial pressure index superior edge first and then around the distal apex to
(>0.15), duplex ultrasonography or DSA. For occlusive be completed on the inferior edge until the two sep-
inflow lesions or progression of distal atherosclerotic arate sutures met, when they were tied together (Fig.
disease, adequate surgical intervention was performed 2d).
including a proximal extension if required. Any acute
thrombotic graft occlusion was managed by throm-
bectomy using the Fogarty manoeuvre.
Statistical analysis
Surgical technique Statistical analysis of primary (PPR) and secondary
patency rates (SPR) as well as limb salvage and patient
The 5 mm diameter, thin-walled and externally sup- survival rates over the time was performed using the
ported ePTFE grafts (Impra/C.R. Bard Inc., Tempe, product-limit method according to Kaplan–Meier with
AZ, U.S.A.) were positioned extra-anatomically with the S-PLUS 4.5 software package (Professional Rel. 2,
the newly designed distal end-to-side anastomosis MathSoft, Inc., Cambridge, MA, U.S.A.).16
being constructed entirely from ePTFE (beginning with
patient no. 44, proximally tapered, 8/5 mm grafts were
used). Bypasses originated from the external iliac, the
common or the proximal superficial femoral artery. Results
The technique of performing the FCPP anastomosis
is illustrated in Figs 1 and 2. About 6 cm length of Between June 1992 and July 1998, 129 patients under-
going 135 bypass procedures were studied. Six patientsePTFE graft was removed and the external spiral stent
denuded. This piece was then sutured end-to-side to received a second graft, four because of definite graft
occlusion and two because of graft infection. Medianthe remaining graft to form a patch. Next, the patch was
sutured under magnification with continuous Prolene follow-up was 45 (range 6–72) months.
There were 89 men and 40 women with a mean age(6/0 for popliteal, 7/0 for tibial or peroneal) to the
recipient artery. The suture line was secured with a of 65.2±10.0 years. At the time of operation, 44% of
patients had diabetes, 72% had medically controlledknot in the middle between the bulbs on each side
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Fig. 2. Schematic representation of the surgical technique to perform the distal FCPP anastomosis. The ePTFE prosthesis is prepared at
its distal end by suturing it to a patch, also made from ePTFE, which is especially configured as a double bulb. The suture line starts
from the centre of the posterior wall (a) and runs first to the proximal corner and thereafter back to the centre of the anterior wall (b). A
second running suture is performed to create the distal part of the FCPP anastomosis (c), with the two sutures meeting to be tied on the
anterior wall (d).
hypertension, 22.5% had had myocardial infarction,
64% had a history of smoking, and 9% had renal
insufficiency on haemodialysis. Indications for oper-
ation were ulcer or gangrene in 70 cases (52%) and
rest pain in 65 cases (48%).
In 95 limbs (70%) at least one previous infrainguinal
bypass operation had failed. There were 19 grafts
(14%) with a zero-vessel run-off and 38 grafts (28%)
with a one-vessel run-off. Seventy-eight grafts (58%)
had a two- or three-vessel run-off. The plantar arch
was incomplete in 71 grafts (52%) and occluded in 24
grafts (18%). There was no perioperative mortality.
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The cumulative survival at 1, 3, and 5 years was 86.7%,
74.1%, and 68.9%, respectively (Fig. 3). Fig. 3. Kaplan–Meier plot of cumulative patient survival. The
dotted lines indicate the 95% confidence intervals. The number atTwenty-seven grafts (20%) failed within 30 days.
each point represents the number of patients at risk and the numberThrombectomy was successful in 22 patients. Early of censored events, respectively.
occlusion was followed by limb loss in three patients.
Another 20 grafts occluded within the first year, all of between two and maximally eight times each. The
duration of patency was thereby prolonged in 43 grafts,which were re-explored with restoration of patency.
Thrombectomy was required during the postoperative 11 of which remained permanently patent.
PPR and SPR at 1, 2, 3, 4, and 5 years were 63.0%,course in altogether 58 grafts, sometimes repeatedly,
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Fig. 4. Cumulative primary (a) and secondary (b) patency rates according to Kaplan–Meier in 135 ePTFE bypass grafts with distal FCPP
anastomosis. The dotted lines indicate the 95 % confidence intervals. The numbers at each point give the number of grafts at risk and the
number of censored events at the beginning of the interval.
44.9%, 35.7%, 33.1% and 27.6% and 74.5%, 55.2%,
44.8%, 43.0%, and 37.6%, respectively (Fig. 4a,b). Re-
cipient arteries were below-knee popliteal (21), anterior
(46) and posterior (52) tibial, and peroneal (16) (Fig.
5). There was no significant difference in PPR or
SPR between the recipient arteries (log-rank test). The
cumulative limb salvage was 86.4%, 78.7%, and 73.2%
at 1, 3, and 5 years, respectively (Fig. 6).
Graft infection occurred in seven patients (5.2%) re-
quiring explantation of the prosthetic graft in five cases
after 1, 6, 9, 14, and 36 months. Re-grafting was later
performed successfully in 2 patients. Major amputation
was required after graft explantation in 3 patients.
Discussion
Autologous vein remains the conduit of choice for
distal revascularisation.1 However, in up to 28% of
patients, vein may be unavailable due to previous
coronary artery bypass surgery, varicose-vein strip-
ping, previous infrainguinal revascularisations, in-
sufficient calibre, or as a result of previous episodes of
thrombophlebitis.4 ePTFE-vein composite grafts have
been shown to be a valuable alternative to all-
autologous infragenicular reconstructions.17 In those
patients in whom no saphenous vein is available, arm
veins, spliced veins, superficial femoral vein, cryo-
preserved saphenous vein, and human umbilical vein
have been used with varying degrees of success.18–22
However, when no venous conduit is available het-
erologous graft materials are required, of which ePTFE
has been most commonly used. Long-term results of
this prosthetic conduit when used entirely for infra- Fig. 5. Postoperative DSA 4 years after an ePTFE bypass graft to
genicular revascularisation procedures, however, are the peroneal artery. Note the characteristic bifurcated double-bulb
configuration of the distal FCPP anastomosis.generally poor. There are only a few clinical studies
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artery below the knee.31 Favourable results for vein
cuffs in femorodistal ePTFE grafts were also dem-
onstrated in retrospective studies.32
The vein cuff is believed to eliminate or at least
diminish the compliance mismatch between a rigid
graft and a small-calibre, more compliant recipient
artery. However, the scientific evidence to support this
hypothesis is lacking. Sottiurai et al.33 concluded from
experimental work that improvement of compliance
mismatch with distal vein patch angioplasty did not
prevent MIH formation within the anastomotic site
but seemed to reduce the extent of MIH in the more
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rigid and less compliant PTFE graft. However, while
Fig. 6. Kaplan–Meier plot of cumulative limb salvage. The dotted ingrowth of endothelial cells on to the flow surface of
lines indicate the 95% confidence intervals. The numbers at each PTFE grafts occurs in dogs, it occurs in human beings
point give the number of limbs at risk and the number of censored
to a much lesser degree. In the absence of livingevents.
endothelial and smooth muscle cells MIH cannot de-
velop. On the other hand, haemodynamics within the
of ePTFE tibial grafts, most of them reporting PPR anastomotic site have been shown to determine the
and SPR of 25% or less.7–9,23 Better results have been development and location of MIH, which, in turn, are
reported by Christenson et al.24 with 4- and 6-year related to its geometric configuration.
cumulative patency rates of 47% and 43%, respectively, This is the first prospective clinical investigation of
for below-knee and 49% for crural distal anastomosis. the FCPP. The elimination of the stagnation point at the
Parsons et al.5 reported 5-year PPR and SPR of 28% floor opposite to the graft entrance may be another
and 43%, respectively. In the present series there was important feature of the FCPP anastomosis, as flow
a high early occlusion rate of 20%. However, the stagnation coincides with a high-pressure zone withinangiographic run-off status as a rough measure of
the anastomotic site, and the development of MIH. Theoutflow resistance characterised the patients in this
FCPP anastomosis strongly resembles two end-to-endseries as mostly poor-risk candidates.7,24,25
anastomoses each with the proximal and distal recipientCaution should be used in interpreting the results of
artery, thus possibly avoiding the basic haemodynamicthe present study for several reasons. The rather high
disadvantages of end-to-side anastomoses.percentage of secondary procedures in the present series
Da Silva et al.34 showed that stable vortices withinreflects a non-selected poor prognosis patient popu-
vein cuffs inhibit anastomotic MIH. Based on theselation.7 In particular, occlusion of the pedal arch artery
observations, another new ePTFE graft design to in-and all three crural arteries was not a contraindication
hibit MIH in small-vessel anastomoses was proposed.35to grafting with distal FCPP anastomosis. In this study,
This development resulted in the Distaflo bypass graftwe did not attempt to diminish outflow resistance by
now available, in which the distal end has the shapecreating an arteriovenous fistula. In a recent study,
of a Miller cuff (Distaflo, Impra/C.R.Bard Inc., Tempe,Hamsho et al. have shown that an adjuvant arterio-
AZ, U.S.A.). Compared with the FCPP, the design ofvenous fistula confers no additional significant clinical
this graft represents a different way of dealing withadvantage over interposition vein cuff alone.26
MIH at the distal end-to-side anastomosis of ePTFEMIH at the distal anastomosis remains a major cause
grafts. The Distaflo design differs from our new ana-of failure in ePTFE bypass grafts to the below-knee
stomosis, because detailed analyses of the complexand crural level.25,27–29
flow field demonstrated only minimal vortex for-A vein cuff was originally suggested as a method
mation in the heel and virtually none in the toe regionof anastomosing mismatched Dacron grafts to smaller
of the FCPP anastomosis. However, both the FCPParteries.30 The modification of a vein cuff reported by
anastomotic design and the Distaflo prosthesis withTaylor et al.11 was shown to achieve high success rates
its pre-shaped distal anastomosis represent alternativewith a 5-year PPR of 54% in a series of 83 tibioperoneal
solutions of anastomotic engineering to overcomeePTFE bypass grafts. In a multicentre randomised
MIH. Although there are differences between theprospective study, using a distal anastomosis in-
shapes and the flow structures generated, both graftsterposition vein cuff as described by Miller et al.,10
aim to minimise anastomotic MIH by eliminating areasthere was a statistically significant advantage when
PTFE bypass grafts were anastomosed to the popliteal of low shear stress.
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